---
figid: PMC11711753__41467_2024_55533_Fig4_HTML
figtitle: Analysis of a phosphoproteomic perturbation dataset in PTMNavigator
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11711753
filename: 41467_2024_55533_Fig4_HTML.jpg
figlink: /pmc/articles/PMC11711753/figure/F4/
number: F4
caption: 'A Edited screenshot from PTMNavigator showing an excerpt from the pathway
  diagram “mTOR Signaling Pathway - hsa04150” and the modified peptides significantly
  regulated by three of the drugs in Bekker-Jensen et al. Note that the authors added
  the node for EGFR. It is not part of the original pathway diagram but is known to
  interact with GRB2 and PI3K. The blue borders indicate kinases whose activity was
  significantly decreased (Score <−0.5, FDR < 0.1) according to KSEA analysis. Top:
  Lapatinib. Middle: Wortmannin. Bottom: Temsirolimus. B Edited screenshot from PTMNavigator
  showing an excerpt from the pathway diagram “MAPK signaling pathway - hsa04010”
  and the modified peptides regulated by two of the drugs in Bekker-Jensen et al.
  Regulated PTMs are colored by the size of the effect (Log2 Fold Change). Left: Cobimetinib.
  Right: Sorafenib. Source data are provided as a Source Data file'
papertitle: 'PTMNavigator: interactive visualization of differentially regulated post-translational
  modifications in cellular signaling pathways'
reftext: Julian Müller, et al. Nat Commun. 2025;16(NA).
year: '2025'
doi: 10.1038/s41467-024-55533-y
journal_title: Nature Communications
journal_nlm_ta: Nat Commun
publisher_name: Nature Publishing Group
keywords: Biochemical networks | Cellular signalling networks | Proteome informatics
  | Post-translational modifications
automl_pathway: 0.7267541
figid_alias: PMC11711753__F4
figtype: Figure
redirect_from: /figures/PMC11711753__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11711753__41467_2024_55533_Fig4_HTML.html
  '@type': Dataset
  description: 'A Edited screenshot from PTMNavigator showing an excerpt from the
    pathway diagram “mTOR Signaling Pathway - hsa04150” and the modified peptides
    significantly regulated by three of the drugs in Bekker-Jensen et al. Note that
    the authors added the node for EGFR. It is not part of the original pathway diagram
    but is known to interact with GRB2 and PI3K. The blue borders indicate kinases
    whose activity was significantly decreased (Score <−0.5, FDR < 0.1) according
    to KSEA analysis. Top: Lapatinib. Middle: Wortmannin. Bottom: Temsirolimus. B
    Edited screenshot from PTMNavigator showing an excerpt from the pathway diagram
    “MAPK signaling pathway - hsa04010” and the modified peptides regulated by two
    of the drugs in Bekker-Jensen et al. Regulated PTMs are colored by the size of
    the effect (Log2 Fold Change). Left: Cobimetinib. Right: Sorafenib. Source data
    are provided as a Source Data file'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - EGFR
  - IGF1R
  - GRB2
  - IRS1
  - BRAF
  - RPTOR
  - TSC2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SLC12A3
  - TSC1
  - TESC
  - RHEB
  - RHEBP1
  - EIF4EBP1
  - AKT1S1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - CHUK
  - EIF2AK3
  - TBC1D7
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - XYLT2
  - SOS1
  - SOS2
  - RICTOR
  - MAPKAP1
  - RPS6
  - GSK3B
  - EIF4B
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - STMN1
  - SMG1
  - MYC
  - Group
  - Metabolite
  - TSC
  - PERK
  - RAS
  - MEK
  - Cobimetinib
  - Sorafenib
---
